Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for thrombocytopenia after AHCT
NCT04478123Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jul 2020
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in Thrombocytopenia, sponsored by Memorial Sloan Kettering Cancer Center. Started Jul 2020; status: completed.
02
Drugs
romiplostim
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT04478123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478123.